Mechanical Thrombectomy

This report from Meddevicetracker includes an analysis of products, current/forecast markets, competitors, and opportunities in the global market for neuroendovascular mechanical thrombectomy devices. Each year, approximately 7.6 million people worldwide experience an ischemic cerebral stroke. The limitations of thrombolytic medication treatment have led to the development and rapid adoption of mechanical thrombectomy for the treatment of acute ischemic stroke. In 2022, sales of mechanical thrombectomy stent retrievers and aspiration devices covered by this analysis totaled approximately $805m. Drivers of this underpenetrated market include a growing elderly population and the rising incidence of acute ischemic stroke. Limiters to this market include stroke treatment delays, patient eligibility restrictions, and limited access to specialty stroke centers in some regions. Markets covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world market, which includes all other countries. The forecast range for this report is 2022–27.

If you are not a subscriber to Meddevicetracker and would like to purchase this report, please send an email to [email protected]. If you would like more information about obtaining a subscription to the Meddevicetracker database and report library, please send an email to [email protected].